Finally, to evaluate the predictive accuracy of DST in guiding therapeutic decisions for lung cancer patients, tumor cells were isolated from a treatment‐naive EGFR‐mutant NSCLC patient using the optimized CD45+ cell depletion enrichment method. This evidence concerns the gene PTPRC and non-small cell lung carcinoma.